Drinking Alcohol Daily May Speed Loss of Nerve Cells & Keto Diet and Other MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how people with MS who drink alcohol on a daily basis may be at risk of losing nerve cells more quickly, according to a...
23 Mars 202211min
Ketogenic Diet Eases Symptoms & ‘Cog Fog’, Spinal Atrophy and Other MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how RRMS patients following a low-carb, high-fat diet for 6 months, showed better physical and mental...
21 Mars 20229min
Immune Reaction to Milk Protein May Explain Link to MS & Self-discovery With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mice immunized with casein showed a nervous system inflammation and demyelination and how this may explain why MS ...
18 Mars 20229min
Stem Cell Therapy Shows Neuroprotective Effects & Spasticity, NfL Blood Test and Other MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how administering NG-01 stem cell therapy directly into the spinal canal of patients with active progressive MS, reduce...
16 Mars 202214min
Masitinib Slows Disability Progression, A Daughter's Diagnosis & Finding Strength With a New Mindset
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, explains how Masitinib significantly slows disability progression in adults with PPMS and non-active SPMS, according to new data...
14 Mars 202213min
Mavenclad Works Best at Reducing Relapses & Managing Fatigue Through Medication
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, covers how MS patients on Mavenclad are less likely to experience a disease relapse than those on other oral DMTs like Gilenya, ...
11 Mars 202211min
Immune System ‘Reset’ by Stem Cell Transplant & Managing Anal Catheter Mishaps
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how a stem cell transplant can reduce relapse rates and ease disability in MS patients, especially th...
9 Mars 202210min
Greater Cancer Risk Linked to Certain Oral DMTs & Supplements for MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how S1P receptor modulators such as Mayzent and Gilenya may be associated with a greater likelihood o...
7 Mars 202212min
